Why Is This Treatment Important?
Nonvalvular atrial fibrillation (NVAF) is a common arrhythmia and an important risk factor for stroke. It is one of several conditions and lifestyle factors that have been identified as risk factors for stroke. It has been estimated that over two million adults in the United States have NVAF. The administration of anticoagulation therapy (medication to prevent blood clots), unless there are contraindications, is an established effective strategy in preventing recurrent stroke in high stroke risk atrial fibrillation patients with transient ischemic attack or prior stroke.
What the Scores Mean
A higher percentage is good because it means more patients received the recommended treatment. However, a lower score does not necessarily indicate poor care. You should consider the overall quality of a facility in addition to individual category scores.
About the Data
The data on this site represent the time period of October 2012 through September 2013 and are the most recent available. They are reported to the Joint Commission as a core measure set in conjunction with the Get with the Guidelines program of the American Heart Association and American Stroke Association. For more information, please visit the Joint Commission website and the American Heart Association and American Stroke Association Get with the Guidelines website.